Elizabeth Trehu, Chief Medical Officer at Jounce Therapeutics, Inc. (JNCE), sold 9,090 shares at $25.06 ($228K) on 2018-03-08, disclosed to the SEC on 2018-03-12.
Open-market sale of $228k JNCE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.06 | 4,545 | $114K | 50.0% |
| 2 | $25.06 | 4,545 | $114K | 50.0% |
| Total | $25.06 avg | 9,090 | $228K | 100% |
| Filing → |
| JNCE | SELL | 2021-03-31 | $136K | — | Filing → |
| JNCE | SELL | 2021-01-22 | $78K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $36K | — | Filing → |